ClearPoint Neuro (CLPT) Enterprise Value (QoQ) (2011 - 2026)
ClearPoint Neuro (CLPT) Enterprise Value (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.42% |
| Mar 31, 2026 | 22.49% |
| Dec 31, 2025 | -20.22% |
| Sep 30, 2025 | 7.95% |
| Jun 30, 2025 | -235.03% |
| Mar 31, 2025 | 38.37% |
| Dec 31, 2024 | 6.83% |
| Sep 30, 2024 | 34.32% |
| Jun 30, 2024 | 7.09% |
| Mar 31, 2024 | -53.04% |
| Dec 31, 2023 | 5.10% |
| Sep 30, 2023 | 8.14% |
| Jun 30, 2023 | 16.38% |
| Mar 31, 2023 | 15.52% |
| Dec 31, 2022 | 7.28% |
| Sep 30, 2022 | 10.29% |
| Jun 30, 2022 | 9.18% |
| Mar 31, 2022 | 8.21% |
| Dec 31, 2021 | 6.16% |
| Sep 30, 2021 | 6.30% |